Influencing of calcium paradox by membrane stabilizing agents: the role of sarcolemma and intercalated disc. 1993

N Tribulova, and J Slezak, and T Ravingerova
Institute for Heart Research, Slovak Academy of Sciences, Bratislava.

The purpose of this study was to focus on the role of the sarcolemma and intercalated disc in the induction and prevention of calcium paradox. Perfusion of the heart with Ca deficient solution produces only minor cytoplasmic ultrastructural changes. More obvious changes are seen in the sarcolemma. The cell surface shows a separation between the layers of the glycocalyx and the cells separate at the fascia adherens. These alterations resulted in the enhanced sarcolemmal membrane permeability, alteration and weakening of intercalated discs junctions. This was accompanied by intracellular accumulation of lanthanum. The application of membrane stabilizing agents, when the normal ultrastructure of the sarcolemma and intercalated disc is maintained, may prevent or at least attenuate the magnitude of deleterious effect of the calcium paradox on the heart. It is concluded that cell membrane significantly participates in the pathogenesis of the Ca paradox damage in the heart.

UI MeSH Term Description Entries
D007811 Lanthanum The prototypical element in the rare earth family of metals. It has the atomic symbol La, atomic number 57, and atomic weight 138.91. Lanthanide ion is used in experimental biology as a calcium antagonist; lanthanum oxide improves the optical properties of glass.
D008297 Male Males
D010477 Perfusion Treatment process involving the injection of fluid into an organ or tissue. Perfusions
D011134 Polysaccharides Long chain polymeric CARBOHYDRATES composed of MONOSACCHARIDES linked by glycosidic bonds. Glycan,Glycans,Polysaccharide
D011464 Epoprostenol A prostaglandin that is a powerful vasodilator and inhibits platelet aggregation. It is biosynthesized enzymatically from PROSTAGLANDIN ENDOPEROXIDES in human vascular tissue. The sodium salt has been also used to treat primary pulmonary hypertension (HYPERTENSION, PULMONARY). Prostacyclin,Prostaglandin I2,Epoprostanol,Epoprostenol Sodium,Epoprostenol Sodium Salt, (5Z,9alpha,11alpha,13E,15S)-Isomer,Flolan,Prostaglandin I(2),Veletri
D002118 Calcium A basic element found in nearly all tissues. It is a member of the alkaline earth family of metals with the atomic symbol Ca, atomic number 20, and atomic weight 40. Calcium is the most abundant mineral in the body and combines with phosphorus to form calcium phosphate in the bones and teeth. It is essential for the normal functioning of nerves and muscles and plays a role in blood coagulation (as factor IV) and in many enzymatic processes. Coagulation Factor IV,Factor IV,Blood Coagulation Factor IV,Calcium-40,Calcium 40,Factor IV, Coagulation
D006023 Glycoproteins Conjugated protein-carbohydrate compounds including MUCINS; mucoid, and AMYLOID glycoproteins. C-Glycosylated Proteins,Glycosylated Protein,Glycosylated Proteins,N-Glycosylated Proteins,O-Glycosylated Proteins,Glycoprotein,Neoglycoproteins,Protein, Glycosylated,Proteins, C-Glycosylated,Proteins, Glycosylated,Proteins, N-Glycosylated,Proteins, O-Glycosylated
D006321 Heart The hollow, muscular organ that maintains the circulation of the blood. Hearts
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D012508 Sarcolemma The excitable plasma membrane of a muscle cell. (Glick, Glossary of Biochemistry and Molecular Biology, 1990) Sarcolemmas

Related Publications

N Tribulova, and J Slezak, and T Ravingerova
January 1985, Basic research in cardiology,
N Tribulova, and J Slezak, and T Ravingerova
January 1985, Research in experimental medicine. Zeitschrift fur die gesamte experimentelle Medizin einschliesslich experimenteller Chirurgie,
N Tribulova, and J Slezak, and T Ravingerova
January 1981, Acta pharmacologica et toxicologica,
N Tribulova, and J Slezak, and T Ravingerova
August 1982, Circulation research,
N Tribulova, and J Slezak, and T Ravingerova
March 1983, Circulation research,
N Tribulova, and J Slezak, and T Ravingerova
October 1982, Acta pharmacologica et toxicologica,
N Tribulova, and J Slezak, and T Ravingerova
January 2014, Frontiers in physiology,
N Tribulova, and J Slezak, and T Ravingerova
January 2012, Frontiers in bioscience (Landmark edition),
Copied contents to your clipboard!